Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;44:649-654
Published online before print September 27, 2004, doi: 10.1161/01.HYP.0000144800.21037.a5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
44/5/649    most recent
01.HYP.0000144800.21037.a5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feoktistov, I.
Right arrow Articles by Biaggioni, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feoktistov, I.
Right arrow Articles by Biaggioni, I.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
Right arrow Receptor pharmacology

(Hypertension. 2004;44:649.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A2B Angiogenic Phenotype

Igor Feoktistov; Sergey Ryzhov; Hongyan Zhong; Anna E. Goldstein; Anton Matafonov; Dewan Zeng; Italo Biaggioni

From the Divisions of Cardiovascular Medicine (I.F., A.E.G.) and Clinical Pharmacology (S.R., A.M., I.B.) and the Departments of Medicine (I.F., A.E.G., I.B.) and Pharmacology (S.R., A.M., I.B.), Vanderbilt University, Nashville, Tenn; and the Department of Drug Research and Pharmacological Sciences (H.Z., D.Z.), CV Therapeutics, Inc, Palo Alto, Calif.

Correspondence to Igor Feoktistov, PhD, 360 PRB, Vanderbilt University, Nashville, TN 37232-6300. E-mail igor.feoktistov{at}vanderbilt.edu

We previously reported that adenosine A2B receptor activation stimulates angiogenesis. Because hypoxia is a potent stimulus for the release of both adenosine and angiogenic factors, we tested the hypothesis that hypoxia alters the expression of adenosine receptors toward an "angiogenic" phenotype. We used human umbilical vein endothelial cells (HUVECs) and bronchial smooth muscle cells (BSMCs) because, under normoxic conditions, adenosine does not release vascular endothelial growth factor (VEGF). HUVECs expressed a characteristic A2A phenotype (the selective A2A agonist CGS21680 was as potent as the nonselective agonist 5'-N-ethylcarboxamidoadenosine [NECA] in generating cAMP). Hypoxia (4.6% O2, 3 hours) decreased A2A mRNA from 1.56±0.3% to 0.16±0.01% of ß-actin expression but increased A2B mRNA from 0.08±0.01% to 0.27±0.05%. Consistent with changes in receptor expression, CGS21680 failed to increase cAMP in hypoxic HUVECs, whereas NECA remained active (A2B phenotype), and NECA increased VEGF release from 9.5±1.0 to 14.2±1.2 pg/mL (P<0.05), indicating that increased A2B receptors were functionally coupled to upregulation of VEGF. Hypoxia had similar effects on BSMCs, increasing A2B mRNA by 2.4±0.3-fold, from 0.42±0.04% to 1.00±0.13% of ß-actin. Whereas NECA had no effect on VEGF release in normoxic BSMCs, it increased VEGF release in hypoxic BSMCs, from 74.6±9.6 to 188.3±16.7 pg/mL (P<0.01), and a selective A2B antagonist, CVT-6694, inhibited this increase. A2B receptors activated a VEGF reporter made unresponsive to hypoxia by mutating its hypoxia-inducible factor-1 (HIF-1) binding element, indicating a mechanism independent of HIF-1. In conclusion, hypoxia modulates the expression of adenosine receptors in human endothelial and smooth muscle cells toward an A2B"angiogenic" phenotype.


Key Words: adenosine • hypoxia • receptors, purinergic • endothelium • vasculature • muscle, smooth • endothelium-derived factors




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Ahmad, S. Ahmad, L. Glover, S. M. Miller, J. M. Shannon, X. Guo, W. A. Franklin, J. P. Bridges, J. B. Schaack, S. P. Colgan, et al.
Adenosine A2A receptor is a unique angiogenic target of HIF-2{alpha} in pulmonary endothelial cells
PNAS, June 30, 2009; 106(26): 10684 - 10689.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
Y.-H. Kim, H.-S. Hwang, Y.-T. Kim, H.-S. Kim, and Y.-W. Park
Modulation of Matrix Metalloproteinase Secretion by Adenosine A3 Receptor in Preeclamptic Villous Explants
Reproductive Sciences, November 1, 2008; 15(9): 939 - 949.
[Abstract] [PDF]


Home page
BloodHome page
T. Eckle, M. Faigle, A. Grenz, S. Laucher, L. F. Thompson, and H. K. Eltzschig
A2B adenosine receptor dampens hypoxia-induced vascular leak
Blood, February 15, 2008; 111(4): 2024 - 2035.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Merighi, A. Benini, P. Mirandola, S. Gessi, K. Varani, C. Simioni, E. Leung, S. Maclennan, P. G. Baraldi, and P. A. Borea
Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1{alpha}, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells
Mol. Pharmacol., August 1, 2007; 72(2): 395 - 406.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Loffler, J. C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig
Physiological Roles of Vascular Nucleoside Transporters
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1004 - 1013.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Mohsenin, M. D. Burdick, J. G. Molina, M. P. Keane, and M. R. Blackburn
Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease
FASEB J, April 1, 2007; 21(4): 1026 - 1036.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. Kong, K. A. Westerman, M. Faigle, H. K. Eltzschig, and S. P. Colgan
HIF-dependent induction of adenosine A2B receptor in hypoxia
FASEB J, November 1, 2006; 20(13): 2242 - 2250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Zhong, Y. Wu, L. Belardinelli, and D. Zeng
A2B Adenosine Receptors Induce IL-19 from Bronchial Epithelial Cells, Resulting in TNF-{alpha} Increase
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 587 - 592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, B. Teng, P. J. Oldenburg, L. C. Katwa, J. B. Schnermann, and S. J. Mustafa
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1875 - H1882.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. A. Sands, H. D. Woolson, G. R. Milne, C. Rutherford, and T. M. Palmer
Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells.
Mol. Cell. Biol., September 1, 2006; 26(17): 6333 - 6346.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Linden
Ups and downs of adenosine
Blood, September 1, 2006; 108(5): 1430 - 1430.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Fortin, D. Harbour, M. Fernandes, P. Borgeat, and S. Bourgoin
Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide
J. Leukoc. Biol., March 1, 2006; 79(3): 574 - 585.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
H. Hyodoh, M. Hori, H. Akiba, M. Tamakawa, K. Hyodoh, and M. Hareyama
Peripheral Vascular Malformations: Imaging, Treatment Approaches, and Therapeutic Issues
RadioGraphics, October 1, 2005; 25(suppl_1): S159 - S171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. H. Adair
Growth regulation of the vascular system: an emerging role for adenosine
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R283 - R296.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Gorlach
Control of Adenosine Transport by Hypoxia
Circ. Res., July 8, 2005; 97(1): 1 - 3.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. P. H. Leung, R. Y. K. Man, and C.-M. Tse
D-Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2756 - H2762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Merighi, A. Benini, P. Mirandola, S. Gessi, K. Varani, E. Leung, S. Maclennan, and P. A. Borea
A3 Adenosine Receptor Activation Inhibits Cell Proliferation via Phosphatidylinositol 3-Kinase/Akt-dependent Inhibition of the Extracellular Signal-regulated Kinase 1/2 Phosphorylation in A375 Human Melanoma Cells
J. Biol. Chem., May 20, 2005; 280(20): 19516 - 19526.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. V. Donoso, R. Lopez, R. Miranda, R. Briones, and J. P. Huidobro-Toro
A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2439 - H2449.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. H. Adair
An Emerging Role for Adenosine in Angiogenesis
Hypertension, November 1, 2004; 44(5): 618 - 620.
[Full Text] [PDF]